Vaccines

The company continues to see pressure on sales from staffing shortages at hospitals, which have limited growth in procedures using J&J products, while inflation has boosted expenses.

A partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn’t lived up to expectations. The companies are now engaged in arbitration.

The White House says it was not in any way involved in China's approval of Pfizer's COVID-19 pill to treat an anticipated wave of infections.

According to a study published in The New England Journal of Medicine, the Johnson & Johnson's and Merck's vaccines for Ebola created lasting antibodies.

Vaccine-maker Moderna has partnered with the biopharmaceutical company Merck to create an effective treatment for skin cancer

Rapper and actor Ice Cube confirmed he lost a $9 million movie deal with Sony Productions because he refused producers' requests to get vaccinated against COVID-19.

Several religious employees of a Massachusetts pharmaceutical company, who claim they were fired for refusing COVID-19 vaccine have filed a lawsuit, led by Alex Jones' attorney.

The largest meat producer in the U.S., Tyson Foods, ended its COVID-19 vaccine mandate for all employees on Oct. 31, the company said on Monday.

COVID-19 vaccine maker Moderna's shares fell on Thursday following the release of the company's third-quarter earnings, which showed a decline in revenue.

GSK reported strong third-quarter earnings and raised its forecast for 2022. However worries about Zantac litigation kept investors on edge.

Pfizer announced an experimental vaccine that, when administered during pregnancy, would protect infants from severe illness for up to six months of life.

Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.

Pfizer is seeking approval from the FDA for its updated COVID-19 booster shot targeting the omicron variant in kids between the ages of 5 and 11.

Pfizer Chairman and CEO Albert Bourla said on Saturday that the coronavirus "is still with us" after he tested positive for the second time in less than two months.

Pfizer plans to provide millions of COVID-19 treatment courses for lower income countries. Access to Paxlovid treatment courses has been severely restricted to poorer countries.

The Centers for Disease Control and Prevention gave final approval to updated COVID-19 vaccines targeting the dominant omicron variant on Thursday.

Pfizer announced on Thursday that a vaccine designed to stop respiratory syncytial virus, or RSV, infections is over 85% effective in older adults.

The producer of the only approved monkeypox vaccine is promising to increase the production of vaccine doses as supply falters and cases increase.

Illinois health care workers who filed a lawsuit against their employers' vaccine mandate were awarded a $10 million settlement after arguing the rule violated Title VII.

Pfizer Chairman and CEO Albert Bourla said he was isolating and taking a course of Paxlovid after testing positive for COVID-19 and experiencing mild symptoms.